
Featuring perspectives from Dr David W Cescon, including the following topics:First-line treatment of metastatic triple-negative breast cancer (mTNBC) in patients not eligible for immunotherapy (0:00)First-line treatment of mTNBC in patients eligible for immunotherapy (12:05)Adverse events (19:39)CME information and select publications
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Gynecologic Cancers — Reviewing Key Presentations from the 2026 ASCO Annual Meeting

Metastatic Bladder Cancer — Rapid Case Review Issue 8

Metastatic Bladder Cancer — Rapid Case Review Issue 7

Breast Cancer — Reviewing Key Presentations from the 2026 ASCO Annual Meeting
Free AI-powered recaps of Oncology Today with Dr Neil Love and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.